We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

1,044 hedge funds and large institutions have $55.2B invested in Thermo Fisher Scientific in 2016 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 332 increasing their positions, 458 reducing their positions, and 65 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more funds holding in top 10

Funds holding in top 10: 7893 (+15)

13% more call options, than puts

Call options by funds: $226M | Put options by funds: $201M

7% more capital invested

Capital invested by funds: $51.5B → $55.2B (+$3.71B)

0.13% less ownership

Funds ownership: 88.79%88.67% (-0.13%)

2% less first-time investments, than exits

New positions opened: 64 | Existing positions closed: 65

1% less funds holding

Funds holding: 1,0551,044 (-11)

28% less repeat investments, than reductions

Existing positions increased: 332 | Existing positions reduced: 458

Holders
1,044
Holders Change
-11
Holders Change %
-1.04%
% of All Funds
27.85%
Holding in Top 10
93
Holding in Top 10 Change
+15
Holding in Top 10 Change %
+19.23%
% of All Funds
2.48%
New
64
Increased
332
Reduced
458
Closed
65
Calls
$226M
Puts
$201M
Net Calls
+$25.2M
Net Calls Change
-$33.8M
Name Holding Trade Value Shares
Change
Change in
Stake
MAM
401
Mastrapasqua Asset Management
Tennessee
$6.09M -$127K -821 -2%
PCM
402
Parsons Capital Management
Rhode Island
$6.07M -$23.1K -150 -0.4%
SCA
403
Stonebridge Capital Advisors
Minnesota
$6M +$142K +920 +2%
FHA
404
First Horizon Advisors
Tennessee
$5.99M +$11.4K +74 +0.2%
TAF
405
Tredje AP-fonden
Sweden
$5.97M -$148K -960 -2%
HighTower Advisors
406
HighTower Advisors
Illinois
$5.91M -$307K -1,994 -5%
IRF
407
IBM Retirement Fund
New York
$5.89M -$2.25M -14,569 -28%
SAM
408
Silvercrest Asset Management
New York
$5.78M -$152K -988 -3%
HCMT
409
Highland Capital Management (Tennessee)
Tennessee
$5.77M -$387K -2,509 -6%
MCM
410
Mitchell Capital Management
Kansas
$5.77M +$5.59M +36,260 New
PPSG
411
Princeton Portfolio Strategies Group
New Jersey
$5.76M -$65.5K -425 -1%
LPL Financial
412
LPL Financial
California
$5.72M -$105K -684 -2%
MIH
413
Madison Investment Holdings
Wisconsin
$5.63M
TCOV
414
Trust Company of Vermont
Vermont
$5.57M +$29.9K +194 +0.6%
CCM
415
Compton Capital Management
Rhode Island
$5.54M +$2.8M +18,147 +101%
MYAM
416
Meiji Yasuda Asset Management
Japan
$5.52M +$228K +1,481 +4%
PA
417
Pinnacle Associates
New York
$5.5M -$30.8K -200 -0.6%
GD
418
Grandfield & Dodd
New York
$5.49M -$61.6K -400 -1%
NCM
419
Novare Capital Management
North Carolina
$5.48M +$200K +1,300 +4%
FIM
420
FourPoints Investment Managers
France
$5.46M -$616K -4,000 -10%
GLRA
421
Gerald L. Ray & Associates
Texas
$5.43M -$23.6K -153 -0.4%
N
422
Nuveen
North Carolina
$5.4M -$4.64M -30,114 -47%
RHDIC
423
R.H. Dinel Investment Counsel
California
$5.31M +$100K +650 +2%
RIL
424
Rothschild Investment LLC
Illinois
$5.26M +$539K +3,500 +12%
M
425
MOTCO
Texas
$5.25M -$1.46M -9,501 -22%

TMO Hedge Fund Activity: Q3 2016 in Review

1,044 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2016, worth a combined $55.2B — up 7.2% from $51.5B a quarter earlier.

Sellers outnumbered buyers: 65 funds closed out of TMO and 64 opened new positions — a net loss of 1 holder — while 458 trimmed existing stakes and 332 added.

The largest buyer was Winslow Capital Management, opening a new position worth an estimated $290M. The largest seller was Capital Research Global Investors, cutting an estimated $250M.

  • 1,044 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2016, down from 1,055 in Q2 2016.
  • Funds reported $55.2B of Thermo Fisher Scientific stock for Q3 2016, up 7.2% quarter-over-quarter.
  • 64 funds opened new Thermo Fisher Scientific positions in Q3 2016 and 65 closed out, a net change of -1 holder.
  • The largest Thermo Fisher Scientific buyer in Q3 2016 was Winslow Capital Management, an estimated $290M added.
  • The largest Thermo Fisher Scientific seller in Q3 2016 was Capital Research Global Investors, an estimated $250M sold.

Based on aggregated 13F filings for Q3 2016.